Anna Rogojina

945 total citations
8 papers, 231 citations indexed

About

Anna Rogojina is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Anna Rogojina has authored 8 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Ophthalmology and 2 papers in Oncology. Recurrent topics in Anna Rogojina's work include Cancer therapeutics and mechanisms (3 papers), Molecular Biology Techniques and Applications (2 papers) and Retinal Diseases and Treatments (2 papers). Anna Rogojina is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Molecular Biology Techniques and Applications (2 papers) and Retinal Diseases and Treatments (2 papers). Anna Rogojina collaborates with scholars based in United States. Anna Rogojina's co-authors include John L. Nitiss, Bong Keun Song, Eldon E. Geisert, Aman Seth, Margarita Mishina, K V Chalam, Sue Jinks-Robertson, Karin C. Nitiss, James M. Berger and Yilun Sun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Anna Rogojina

8 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Rogojina United States	6	177	50	39	20	19	8	231
Sheetal Pundir Canada	8	87 0.5×	17 0.3×	15 0.4×	11 0.6×	11 0.6×	15	188
Trevor Chapman United Kingdom	9	234 1.3×	62 1.2×	17 0.4×	2 0.1×	11 0.6×	10	340
Ook-Joon Yoo South Korea	7	147 0.8×	22 0.4×	36 0.9×		21 1.1×	13	208
Thomas Mencken United States	4	129 0.7×	20 0.4×	3 0.1×	10 0.5×	21 1.1×	6	248
Hannah Whitmore United States	8	71 0.4×	5 0.1×	41 1.1×	2 0.1×	25 1.3×	12	142
Yoann Menon France	9	267 1.5×	16 0.3×	5 0.1×	3 0.1×	3 0.2×	9	327
Helin Vakifahmetoglu-Norberg Sweden	5	192 1.1×	26 0.5×	8 0.2×	1 0.1×	6 0.3×	9	354
Lung-Chih Yu Taiwan	9	141 0.8×	10 0.2×	17 0.4×		6 0.3×	10	323
Miyoung Nam South Korea	9	119 0.7×	41 0.8×	2 0.1×	2 0.1×	9 0.5×	17	209
Fanni Molnár United States	5	57 0.3×	17 0.3×	16 0.4×		29 1.5×	13	143

Countries citing papers authored by Anna Rogojina

Since Specialization

Citations

This map shows the geographic impact of Anna Rogojina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rogojina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rogojina more than expected).

Fields of papers citing papers by Anna Rogojina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rogojina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rogojina. The network helps show where Anna Rogojina may publish in the future.

Co-authorship network of co-authors of Anna Rogojina

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rogojina. A scholar is included among the top collaborators of Anna Rogojina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rogojina. Anna Rogojina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Rogojina, Anna, Yilun Sun, James M. Berger, et al.. (2020). Trapped topoisomerase II initiates formation of de novo duplications via the nonhomologous end-joining pathway in yeast. Proceedings of the National Academy of Sciences. 117(43). 26876–26884. 20 indexed citations

2.

Li, Cong, Madeline Fort, Lingming Liang, et al.. (2020). 718 AMG 509, a STEAP1 x CD3 bispecific XmAb^® 2+1 immune therapy, exhibits avidity-driven binding and preferential killing of high STEAP1-expressing prostate and Ewing sarcoma cancer cells. SHILAP Revista de lepidopterología. A430.1–A430. 2 indexed citations

3.

Nitiss, John L., et al.. (2012). Topoisomerase Assays. Current Protocols in Pharmacology. 57(1). Unit 3.3.–Unit 3.3.. 80 indexed citations

4.

Rogojina, Anna, et al.. (2010). Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF.. PubMed. 16. 2175–84. 8 indexed citations

5.

Rogojina, Anna, et al.. (2009). Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor.. PubMed. 15. 60–9. 38 indexed citations

6.

Rogojina, Anna & John L. Nitiss. (2008). Isolation and Characterization of mAMSA-hypersensitive Mutants. Journal of Biological Chemistry. 283(43). 29239–29250. 14 indexed citations

7.

Rogojina, Anna, et al.. (2003). Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines.. PubMed. 9. 482–96. 68 indexed citations

8.

Rogojina, Anna, et al.. (2003). Technical Brief Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact